View in EDS PDF Full Text

Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy.

Saved in:
Bibliographic Details
Title: Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy.
Authors: Lee YH; Department of Rehabilitation Medicine, Hanyang University Medical Center, Seoul, Korea., Choi KV, Moon JH, Jun HJ, Kang HR, Oh SI, Kim HS, Um JS, Kim MJ, Choi YY, Lee YJ, Kim HJ, Lee JH, Son SM, Choi SJ, Oh W, Yang YS
Source: Journal of translational medicine [J Transl Med] 2012 Mar 23; Vol. 10, pp. 58. Date of Electronic Publication: 2012 Mar 23.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 22443810
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+YH%22">Lee YH</searchLink>; Department of Rehabilitation Medicine, Hanyang University Medical Center, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Choi+KV%22">Choi KV</searchLink><br /><searchLink fieldCode="AU" term="%22Moon+JH%22">Moon JH</searchLink><br /><searchLink fieldCode="AU" term="%22Jun+HJ%22">Jun HJ</searchLink><br /><searchLink fieldCode="AU" term="%22Kang+HR%22">Kang HR</searchLink><br /><searchLink fieldCode="AU" term="%22Oh+SI%22">Oh SI</searchLink><br /><searchLink fieldCode="AU" term="%22Kim+HS%22">Kim HS</searchLink><br /><searchLink fieldCode="AU" term="%22Um+JS%22">Um JS</searchLink><br /><searchLink fieldCode="AU" term="%22Kim+MJ%22">Kim MJ</searchLink><br /><searchLink fieldCode="AU" term="%22Choi+YY%22">Choi YY</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+YJ%22">Lee YJ</searchLink><br /><searchLink fieldCode="AU" term="%22Kim+HJ%22">Kim HJ</searchLink><br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink><br /><searchLink fieldCode="AU" term="%22Son+SM%22">Son SM</searchLink><br /><searchLink fieldCode="AU" term="%22Choi+SJ%22">Choi SJ</searchLink><br /><searchLink fieldCode="AU" term="%22Oh+W%22">Oh W</searchLink><br /><searchLink fieldCode="AU" term="%22Yang+YS%22">Yang YS</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101190741%22">Journal of translational medicine</searchLink> [J Transl Med] 2012 Mar 23; Vol. 10, pp. 58. <i>Date of Electronic Publication: </i>2012 Mar 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101190741 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1479-5876 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214795876%22">14795876 </searchLink><i>NLM ISO Abbreviation: </i>J Transl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=22443810
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/1479-5876-10-58
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 58
    Titles:
      – TitleFull: Safety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee YH
      – PersonEntity:
          Name:
            NameFull: Choi KV
      – PersonEntity:
          Name:
            NameFull: Moon JH
      – PersonEntity:
          Name:
            NameFull: Jun HJ
      – PersonEntity:
          Name:
            NameFull: Kang HR
      – PersonEntity:
          Name:
            NameFull: Oh SI
      – PersonEntity:
          Name:
            NameFull: Kim HS
      – PersonEntity:
          Name:
            NameFull: Um JS
      – PersonEntity:
          Name:
            NameFull: Kim MJ
      – PersonEntity:
          Name:
            NameFull: Choi YY
      – PersonEntity:
          Name:
            NameFull: Lee YJ
      – PersonEntity:
          Name:
            NameFull: Kim HJ
      – PersonEntity:
          Name:
            NameFull: Lee JH
      – PersonEntity:
          Name:
            NameFull: Son SM
      – PersonEntity:
          Name:
            NameFull: Choi SJ
      – PersonEntity:
          Name:
            NameFull: Oh W
      – PersonEntity:
          Name:
            NameFull: Yang YS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 03
              Text: 2012 Mar 23
              Type: published
              Y: 2012
          Identifiers:
            – Type: issn-electronic
              Value: 1479-5876
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Journal of translational medicine
              Type: main
ResultId 1